How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages
Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him ...
Aug 24, 2026
0
5









